Identification of a human airway epithelial cell subpopulation with altered biophysical, molecular, and metastatic properties.
PubWeight™: 0.75‹?›
Published in Cancer Prev Res (Phila) on July 28, 2017
Authors
Paul C Pagano1, Linh M Tran2,3, Nawal Bendris4, Sean O'Byrne5, Henry T Tse5, Shivani Sharma6,7, Jonathan W Hoech2,3, Stacy J Park2,3, Elvira L Liclican2,3, Zhe Jing2,3, Rui Li1, Kostyantyn Krysan2,3, Manash K Paul2,3, Yari Fontebasso2,3, Jill E Larsen8, Shaina Hakimi2,3, Atsuko Seki9, Michael C Fishbein9, James K Gimzewski6,7, Dino Di Carlo5,7,10, John D Minna11, Tonya C Walser2,3, Steven M Dubinett12,2,3,7,9,10,13
Author Affiliations
1: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.
2: Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
3: Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
4: Department of Cell Biology, UT Southwestern Medical Center, Dallas, Texas.
5: Department of Bioengineering, UCLA, Los Angeles, California.
6: Department of Chemistry and Biochemistry, UCLA, Los Angeles, California.
7: California NanoSystems Institute, Los Angeles, California.
8: QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
9: Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
10: Jonsson Comprehensive Cancer Center, Los Angeles, California.
11: Hamon Center for Therapeutic Oncology Research and Departments of Medicine and Pharmacology, UT Southwestern Medical Center, Dallas, Texas.
12: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California. sdubinett@mednet.ucla.edu.
13: VA Greater Los Angeles Health Care System, Los Angeles, California.
Articles by these authors ⇆